Carisoprodol - Generic Drug Details
✉ Email this page to a colleague
What are the generic sources for carisoprodol and what is the scope of freedom to operate?
Carisoprodol
is the generic ingredient in three branded drugs marketed by Mylan Speciality Lp, Able, Accelrx Labs, Allied, Aurobindo Pharma, Chartwell Rx, Epic Pharma Llc, Hikma Intl Pharms, Natco, Nostrum Labs Inc, Novast Labs, Orient Pharma Co Ltd, Oxford Pharms, Pioneer Pharms, Sandoz, Sciegen Pharms Inc, Strides Pharma, Sun Pharm Inds Ltd, Sun Pharm Industries, Wanbang Biopharms, Watson Labs, Watson Labs Teva, Wilshire Pharms Inc, and Schering, and is included in twenty-six NDAs. Additional information is available in the individual branded drug profile pages.There are sixteen drug master file entries for carisoprodol. Twenty-seven suppliers are listed for this compound.
Summary for carisoprodol
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 24 |
| NDAs: | 26 |
| Drug Master File Entries: | 16 |
| Finished Product Suppliers / Packagers: | 27 |
| Raw Ingredient (Bulk) Api Vendors: | 83 |
| Clinical Trials: | 4 |
| Patent Applications: | 7,076 |
| Drug Prices: | Drug price trends for carisoprodol |
| What excipients (inactive ingredients) are in carisoprodol? | carisoprodol excipients list |
| DailyMed Link: | carisoprodol at DailyMed |
Recent Clinical Trials for carisoprodol
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Ache Laboratorios Farmaceuticos S.A. | Phase 3 |
| Farmoquimica S.A. | Phase 3 |
| Pharmagenix Projetos em Medicina Farmacêutica Ltda. | Phase 3 |
Pharmacology for carisoprodol
| Drug Class | Muscle Relaxant |
| Physiological Effect | Centrally-mediated Muscle Relaxation |
Medical Subject Heading (MeSH) Categories for carisoprodol
Anatomical Therapeutic Chemical (ATC) Classes for carisoprodol
US Patents and Regulatory Information for carisoprodol
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Orient Pharma Co Ltd | CARISOPRODOL | carisoprodol | TABLET;ORAL | 205085-001 | Oct 28, 2014 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Pioneer Pharms | CARISOPRODOL | carisoprodol | TABLET;ORAL | 089390-001 | Oct 13, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Wanbang Biopharms | CARISOPRODOL | carisoprodol | TABLET;ORAL | 081025-001 | Apr 13, 1989 | AA | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Hikma Intl Pharms | CARISOPRODOL | carisoprodol | TABLET;ORAL | 040124-001 | Jan 24, 1996 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
